Ground Fluor Pharmaceuticals

Lincoln, United States Founded: 2012 • Age: 14 yrs
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
Request Access

About Ground Fluor Pharmaceuticals

Ground Fluor Pharmaceuticals is a company based in Lincoln (United States) founded in 2012.. Ground Fluor Pharmaceuticals operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, AZI and Nanovista, among others.

  • Headquarter Lincoln, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ground Fluor Pharmaceuticals

  • Total Funding
  • Total Rounds 5
  • Last Round
  • First Round

    (15 Jun 2012)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2014 Amount Series A - Ground Fluor Pharmaceuticals Valuation

investors

Apr, 2014 Amount Grant - Ground Fluor Pharmaceuticals Valuation

investors

Apr, 2014 Amount Grant - Ground Fluor Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ground Fluor Pharmaceuticals

Ground Fluor Pharmaceuticals has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include America’s Seed Fund and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital fund backed by the US Government
Founded Year Domain Location
A government-backed foundation providing seed-stage investments to support small businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ground Fluor Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ground Fluor Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ground Fluor Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ground Fluor Pharmaceuticals

Ground Fluor Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, AZI and Nanovista, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Radioisotope technologies and services are developed and provided by ARTMS.
domain founded_year HQ Location
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
domain founded_year HQ Location
Devices and radioisotopes for nuclear imaging are provided by Niowave.
domain founded_year HQ Location
Radiopharmaceuticals for diagnostic imaging are developed and produced.
domain founded_year HQ Location
Multimodal visualization agents are developed for image-guided interventions.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ground Fluor Pharmaceuticals

Frequently Asked Questions about Ground Fluor Pharmaceuticals

When was Ground Fluor Pharmaceuticals founded?

Ground Fluor Pharmaceuticals was founded in 2012.

Where is Ground Fluor Pharmaceuticals located?

Ground Fluor Pharmaceuticals is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.

What does Ground Fluor Pharmaceuticals do?

Ground Fluor Pharmaceuticals was founded in 2012 in Lincoln, United States, within the biomedical sector. Proprietary chemistry is developed for synthesizing pharmaceutical compounds, particularly Fluorine F-18 agents used in positron emission tomography imaging. The SWIFT platform technology, known as Swift Iodonium Fluorine Tagging, enables production of F18 radiopharmaceuticals with higher yields, potency, and reliability compared to existing methods. Pipeline products encompass 18F-m-Fluorobenzylguanidine, 18F-FPEB, 6-18F-Fluoro-L-DOPA, and 6-18F-Fluorophenylalanine.

Who are the top competitors of Ground Fluor Pharmaceuticals?

Ground Fluor Pharmaceuticals's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.

Who are Ground Fluor Pharmaceuticals's investors?

Ground Fluor Pharmaceuticals has 2 investors. Key investors include America’s Seed Fund, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available